Resultados de la búsqueda

Heras-Murillo I, Mañanes D, Munné P, Núñez V, Herrera J, Catalá-Montoro M, Alvarez M, Del Pozo MA, Melero I, Wculek SK, Sancho D. Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse. Nat Commun (2025) 16:3369-3386
Link to the full text in Repisalud

Benedicto I, Hamczyk MR, Dorado B, Andrés V. Vascular cell types in progeria: victims or villains? Trends Mol Med (2025) S1471-4914:00056-5

Real C, Párraga R, Martínez-Gómez J, Beneito-Dura M, González-Calvo E, Diaz-Munoz R, Fernández-Acín P, Gutierrez-Ortiz E, Garcia-Cocera M, Sánchez-González J, Pizarro G, García-Lunar I, Galán-Arriola C, Fernández-Alvira JM, De Miguel M, de Cos-Gandoy A, Bodega P, Pérez de Isla L, Fernandez-Ortiz A, Ibáñez B, Santos-Beneit G, Fuster V, Fernández-Jiménez R. Impact of Cumulative Sleep Duration on Cardiac Structural Remodeling in Asymptomatic Adolescents. JACC Cardiovasc Imaging (2025) S1936-878X:00252-9

Fernández-Gallego N, Anega B, Luengo-Arias S, Bizkarguenaga M, Gil-Redondo R, Embade N, Navarrete-Arias L, Ramírez-Huesca M, Álvarez-Corrales E, Dosil SG, Castillo-González R, Rojas-Gomez A, Espeleta I, Martínez-Martínez S, Alfranca A, G de Yebenes V, Martín-Cófreces NB, Aragonés J, Martin P, Millet O, Sánchez-Madrid F, Cibrian D. Restricting SLC7A5-mediated Leucine uptake in T cells prevents acute GVHD and maintains GVT response. EMBO Mol Med (2025) May 5 [Epub ahead of print]

Martinez-Val A, Van der Hoeven L, Bekker-Jensen DB, Jørgensen MM, Nors J, Franciosa G, Andersen CL, Bramsen JB, Olsen JV. Proteomics of colorectal tumors identifies the role of CAVIN1 in tumor relapse. MOL SYST BIOL (2025) 21:776-806
Link to the full text in Repisalud

Sendra M, McDole K, de Dios Hourcade J, Temiño S, Raiola M, Guignard L, Keller PJ, Domínguez JN, Torres M. Myocardium and endocardium of the early mammalian heart tube arise from independent multipotent lineages specified at the primitive streak. Dev Cell (2025) S1534-5807:00292-8

Sarno F, Tenorio J, Perea S, Medina L, Pazo-Cid R, Juez I, Garcia-Carbonero R, Feliu J, Guillen-Ponce C, Lopez-Casas PP, Guerra C, Duran Y, López-Acosta JF, Alonso C, Esquivel E, Dopazo A, Akshinthala D, Muthuswamy SK, Lapunzina P, Bockorny B, Hidalgo M. A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial. CLIN CANCER RES (2025) 31:278-287

Garcia-Pavia P, Bilen O, Burroughs M, Costabel JP, de Barros Correia E, Dybro AM, Elliott P, Lakdawala NK, Mann A, Nair A, Nassif ME, Poulsen SH, Reant P, Schulze PC, Wang A, Berhane I, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Meng L, Sohn R, Wohltman A, Fifer MA; MAPLE-HCM Study Investigators. Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline Characteristics. JACC Heart Fail (2025) 13:346-357
Link to the full text in Repisalud

Desai MY, Nissen SE, Abraham T, Olivotto I, Garcia-Pavia P, Lopes RD, Verheyen N, Wever-Pinzon O, Wolski K, Jaber W, Mitchell L, Davey D, Myers J, Rano T, Bhatia V, Zhong Y, Carter-Bonanza S, Florea V, Aronson R, Owens AT; ODYSSEY-HCM Investigators. Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Design, Rationale, and Baseline Characteristics of ODYSSEY-HCM. JACC Heart Fail (2025) 13:358-370
Link to the full text in Repisalud

Saberi S, Abraham TP, Choudhury L, Barriales-Villa R, Elliott PM, Nassif ME, Oreziak A, Owens AT, Tower-Rader A, Rader F, Garcia-Pavia P, Olivotto I, Coats CJ, Fifer MA, Sherrid MV, Solomon SD, Watkins H, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Melloni C, Meng L, Wei J, Maron MS, Masri A; FOREST-HCM Steering Committee and Investigators. Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCM. JACC Heart Fail (2025) 13:102496